IDYA Market Cap History



Below is a table of the IDYA market cap history going back to 5/23/2019:

Date IDYA Market Cap
5/23/2019217.97M
8/1/2019143.58M
8/7/2019120.65M
11/1/2019124.43M
3/13/202081.99M
5/5/2020131.17M
8/3/2020333.83M
11/6/2020385.17M
3/15/2021766.82M
5/3/2021682.14M
8/2/2021901.31M
11/8/2021909.69M
3/14/2022470.09M
5/5/2022372.10M
8/9/2022582.51M
11/3/2022856.42M
3/3/2023836.13M
5/5/20231.09B
8/4/20231.26B
11/3/20231.87B

Also see: IDYA Shares Outstanding History
and IDYA YTD Return
IDYA Historical Market Cap:
+61.99% CAGR
IDYA Historical Market Cap: +61.99% CAGR

Mouse over chart for data details
5/23/2019 ...11/3/2023
IDEAYA Biosciences is a synthetic lethality-focused precision medicine oncology company engaged in the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Co.'s primary synthetic lethality product candidate is IDE397, a clinical-stage methionine adenosyltransferase 2a inhibitor for patients with solid tumors having methylthioadenosine phosphorylase deletions. Co. is enrolling patients into a Phase 1 clinical trial designated as IDE397-001 to evaluate IDE397. Co. is targeting poly (ADP-ribose) glycohydrolase for patients having tumors with a defined biomarker based on genetic mutations and/or molecular signatures. We show 20 historical shares outstanding datapoints in our IDYA shares outstanding history coverage, used to compute IDYA market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing IDYA market cap history over the course of time is important for investors interested in comparing IDYA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of IDYA versus a peer is one thing; comparing IDYA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like IDYA can fluctuate over the course of history. With this page we aim to empower investors researching IDYA by allowing them to research the IDYA market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree IDYA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
IDEAYA Biosciences (IDYA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

IGAP Market Cap History
IGMS Market Cap History
IIN Market Cap History
IKNA Market Cap History
IKT Market Cap History
ILMN Market Cap History
IMAC Market Cap History
IMDZ Market Cap History
IMGN Market Cap History
IMGO Market Cap History
More Healthcare companies »

 

IDYA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.